Thieme E-Books & E-Journals -
Back
Pneumologie 2020; 74(S 01): 133
DOI: 10.1055/s-0039-3403366
Posterbegehung (PO25) – Sektion Pneumologische Onkologie
NSCLC: Systemtherapie bei molekularem Treiber
Georg Thieme Verlag KG Stuttgart · New York

Frühe Clearance von Plasma-EGFR-Mutationen als Prädiktor für das Ansprechen auf Osimertinib und Vergleichs-EGFR-TKIs in der FLAURA-Studie

S Bohnet
1   Universitätsklinikum Schleswig‐holstein, Campus Lübeck
,
C Zhou
2   Shanghai Pulmonary Hospital, Tongji University
,
F Imamura
3   Department of Thoracic Oncology, Osaka International Cancer Institute
,
Y Cheng
4   Department of Oncology, Jilin Province Cancer Hospital
,
I Okamoto
5   Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University
,
BC Cho
6   Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine
,
MC Lin
7   Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University
,
M Majem
8   Department of Medical Oncology, Hospital de la Santa Creu I Sant Pau
,
O Gautschi
9   University of Berne and Cantonal Hospital of Lucerne
,
JE Gray
10   Department of Thoracic Oncology, Moffitt Cancer Center and Research Institute
,
MJ Boyer
11   Department of Medical Oncology, Chris Oʼbrien Lifehouse
,
J Chmielecki
12   Translational Sciences, Imed Biotech Unit, Astrazeneca
,
R Hartmaier
13   Astrazeneca
,
K Bulusu
13   Astrazeneca
,
JC Barrett
13   Astrazeneca
,
R Hodge
13   Astrazeneca
,
M Saggese
13   Astrazeneca
,
A McKeown
13   Astrazeneca
,
SS Ramalingam
14   Emory University, Winship Cancer Institute
,
H Bischoff
15   Thoraxklinik Heidelberg gGmbH
› Author Affiliations